From January 1, 2024 to March 31, 2024, the company has repurchased 1,148,000 shares, representing 0.67% for CNY 13.11 million. With this, the company has completed the repurchase of 1,872,500 shares, representing 1.1% for CNY 22.08 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.49 CNY | -4.66% | -10.53% | -14.28% |
1st Jan change | Capi. | |
---|---|---|
-14.28% | 307M | |
+19.40% | 8.71B | |
+6.26% | 7.81B | |
+7.42% | 6.69B | |
-6.19% | 3.78B | |
-6.64% | 3.77B | |
-3.06% | 1.41B | |
-26.54% | 1.13B | |
+20.86% | 1.07B | |
-10.58% | 906M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.